The DEA Drew a Line Around Kratom. Tennessee Erased It.

The DEA sent two notices to the Federal Register on July 1 that will put high-concentration 7-hydroxymitragynine — 7-OH, the compound turning up in gas-station “kratom shots” — into Schedule I, next to heroin. The Federal Register notice sets a specific line: products with more than 0.050% 7-OH by dry weight. Below that line, plain botanical kratom, the ground leaf people have chewed and brewed for generations, isn’t touched.

That threshold is the whole story, and it’s the thing Tennessee’s new law refuses to draw.

Tennessee’s kratom ban, “Matthew Davenport’s Law,” took effect July 1 — the same day the DEA moved. It’s named for a 27-year-old Chattanooga man who died after combining kratom with a prescription medication. Under the new law, simple possession of kratom, any kratom, is a Class A misdemeanor; manufacturing or selling it is a Class C felony, up to 15 years. There’s no dry-weight cutoff, no carve-out for the leaf your grandmother’s generation might have used for pain. It bans the plant.

That’s the distinction that keeps getting lost — including in a lot of our own novel and emerging substances coverage — and it matters clinically, not just semantically. Whole-leaf kratom binds opioid receptors weakly and partially — its effects plateau, which is why the fatal-overdose data on kratom alone (as opposed to kratom mixed with other drugs) has stayed thin even as use has grown. 7-OH extract is different chemically: it’s a much more potent, more efficacious agonist at the same receptors, concentrated through processing until it behaves like a conventional opioid — full-blown dependence, real overdose risk, the profile that’s been driving poison-control calls and ER visits. Addiction physician Andrew Kolodny put it to Rolling Stone as vodka versus beer — same base ingredient, wildly different dose. Even the American Kratom Association, an industry group with every incentive to fight scheduling, came out in support of the DEA action, telling states plainly: “Ban 7-OH because it is not kratom.”

Tennessee didn’t take that advice, and the people absorbing the cost aren’t 7-OH manufacturers — they’re the ones using the leaf itself to stay off something worse. Ashlee Krouse, who is in recovery from heroin use, told WSMV her biggest fear is straightforward: “the risk of people going back out to opioids that may have used kratom to get off of opioids.” A local recovery clinic voiced the same worry — that a plant ban could reverse hard-won progress on overdose numbers, not because kratom is safe in every form, but because taking away the taper tool doesn’t remove the reason someone reached for it.

The DEA’s 30-day clock means the federal rule won’t bind until early August, and it only ever reaches concentrated extract. Tennessee’s ban is already in force and reaches everyone. Good drug policy is supposed to get more precise as the evidence comes in — see our policy-funding coverage for how that’s playing out elsewhere. On kratom, the federal government drew the line at the molecule that’s actually causing harm. Tennessee drew it around the whole plant, and around every person who was using it to stay alive.